{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Neonatal cholestasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_ursodeoxycholic_acid",
          "name": "Ursodeoxycholic acid"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_silibinin",
          "name": "Silibinin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_cholestyramine",
          "name": "Cholestyramine"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_rifampicin",
          "name": "Rifampicin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_deferasirox",
          "name": "Deferasirox"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_bile_acid_sequestrants",
          "name": "Bile acid sequestrants"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_diltiazem",
          "name": "Diltiazem"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_vitamin_e",
          "name": "Vitamin E"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_lactulose",
          "name": "Lactulose"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_n_acetylcysteine",
          "name": "N-acetylcysteine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_metformin",
          "name": "Metformin"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.84,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.75,
          "pk_pd_feasibility": 0.85,
          "indication_plausibility": 0.9,
          "safety_risk": 0.2,
          "graph_bonus": 0.25,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 2.15,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Ursodeoxycholic acid acts on bile acid transporters and supports the pathway leading to neonatal cholestasis."
          ],
          "safety_risk": [
            "Potential adverse effects have been noted but are outweighed by benefits in improving clinical symptoms."
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.75,
          "indication_plausibility": 0.85,
          "safety_risk": 0.2,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.5,
          "contradiction_weight": 0.8,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Silibinin affects bile acid metabolism and supports the indication for neonatal cholestasis."
          ],
          "safety_risk": [
            "Adverse effects are possible but not clearly stated in the literature."
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.75,
          "safety_risk": 0.1,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.3,
          "contradiction_weight": 0.4,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Cholestyramine reduces bile acid reabsorption, which could be beneficial."
          ],
          "safety_risk": [
            "Less clear safety and efficacy specific to neonatal cholestasis."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.6,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.65,
          "safety_risk": 0.15,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.1,
          "contradiction_weight": 0.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Rifampicin may have effects related to bile acid synthesis."
          ],
          "safety_risk": [
            "Potential risks not well defined in neonatal context."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.65,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.7,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.0,
          "contradiction_weight": 0.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Fenofibrate aids lipid metabolism and may influence bile acid processes."
          ],
          "safety_risk": [
            "Safety in neonates is not well documented."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.5,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.3,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.4,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Deferasirox might not have a clear relationship with neonatal cholestasis."
          ],
          "safety_risk": [
            "Safety concerns are higher, and efficacy unclear."
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "Mechanism of action and efficacy for neonatal cholestasis is not strongly supported."
        ]
      },
      {
        "hypothesis_id": "H7",
        "score": 0.68,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.7,
          "safety_risk": 0.2,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.1,
          "contradiction_weight": 0.5,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Bile acid sequestrants act on bile acid metabolism."
          ],
          "safety_risk": [
            "Potential risks exist, though patient benefit has not been clearly established."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.55,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.5,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.3,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Diltiazem's effects on bile acid transporters are less clear."
          ],
          "safety_risk": [
            "Low efficacy and concern for side effects."
          ]
        },
        "confidence": "low",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.5,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.55,
          "safety_risk": 0.25,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0.5,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Vitamin E's benefit in neonatal cholestasis is unclear."
          ],
          "safety_risk": [
            "Concerns exist around administration in neonates."
          ]
        },
        "confidence": "low",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.52,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.35,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.55,
          "safety_risk": 0.2,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 0.4,
          "contradiction_weight": 0.4,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Lactulose might improve gastrointestinal function."
          ],
          "safety_risk": [
            "Potential utility not well documented in this condition."
          ]
        },
        "confidence": "low",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.45,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.3,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.45,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 0.4,
          "contradiction_weight": 0.5,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "N-acetylcysteine shows potential liver-protective effects."
          ],
          "safety_risk": [
            "Limited evidence specific to cholestasis in neonates."
          ]
        },
        "confidence": "low",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H12",
        "score": 0.48,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.3,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.5,
          "safety_risk": 0.25,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 0.3,
          "contradiction_weight": 0.4,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Metformin is less relevant to neonates."
          ],
          "safety_risk": [
            "Potential risks are significant and not well studied."
          ]
        },
        "confidence": "low",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H3",
      "H7",
      "H5",
      "H4",
      "H8",
      "H10",
      "H6",
      "H9",
      "H12",
      "H11"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_ursodeoxycholic_acid",
          "type": "Drug",
          "label": "Ursodeoxycholic acid",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_silibinin",
          "type": "Drug",
          "label": "Silibinin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cholestyramine",
          "type": "Drug",
          "label": "Cholestyramine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rifampicin",
          "type": "Drug",
          "label": "Rifampicin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_deferasirox",
          "type": "Drug",
          "label": "Deferasirox",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bile_acid_sequestrants",
          "type": "Drug",
          "label": "Bile acid sequestrants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_diltiazem",
          "type": "Drug",
          "label": "Diltiazem",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vitamin_e",
          "type": "Drug",
          "label": "Vitamin E",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lactulose",
          "type": "Drug",
          "label": "Lactulose",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_n_acetylcysteine",
          "type": "Drug",
          "label": "N-acetylcysteine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_metformin",
          "type": "Drug",
          "label": "Metformin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_neonatal_cholestasis",
          "type": "Disease",
          "label": "Neonatal cholestasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_bile_acid_transporters",
          "type": "Target",
          "label": "Bile acid transporters",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_bile_acid_homeostasis",
          "type": "Pathway",
          "label": "Bile acid homeostasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_ursodeoxycholic_acid",
          "type": "Target",
          "label": "OffTargetUrsodeoxycholicAcid",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ursodeoxycholic_acid",
          "type": "Pathway",
          "label": "RiskPathwayUrsodeoxycholicAcid",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ursodeoxycholic_acid",
          "type": "Phenotype",
          "label": "AdversePhenotypeUrsodeoxycholicAcid",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_silibinin",
          "type": "Target",
          "label": "OffTargetSilibinin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_silibinin",
          "type": "Pathway",
          "label": "RiskPathwaySilibinin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_silibinin",
          "type": "Phenotype",
          "label": "AdversePhenotypeSilibinin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Ursodeoxycholic acid",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Silibinin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Cholestyramine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Rifampicin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Deferasirox",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Bile acid sequestrants",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Diltiazem",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Vitamin E",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Lactulose",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "N-acetylcysteine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Metformin",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_ursodeoxycholic_acid",
          "target": "target_bile_acid_transporters",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "普遍用于改善胆汁酸的排泄"
        },
        {
          "source": "drug_silibinin",
          "target": "target_bile_acid_transporters",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "研究显示对胆盐代谢有影响"
        },
        {
          "source": "drug_cholestyramine",
          "target": "target_bile_acid_transporters",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "减少胆汁酸的重吸收"
        },
        {
          "source": "drug_rifampicin",
          "target": "pathway_bile_acid_homeostasis",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "可能影响胆汁酸合成"
        },
        {
          "source": "drug_fenofibrate",
          "target": "pathway_bile_acid_homeostasis",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "有助于脂质代谢"
        },
        {
          "source": "drug_deferasirox",
          "target": "disease_neonatal_cholestasis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可能缓解与胆汁酸代谢相关的症状"
        },
        {
          "source": "drug_bile_acid_sequestrants",
          "target": "pathway_bile_acid_homeostasis",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "通过结合胆汁酸减轻胆汁淤积"
        },
        {
          "source": "drug_diltiazem",
          "target": "target_bile_acid_transporters",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "已知对某些相关转运蛋白有影响"
        },
        {
          "source": "drug_vitamin_e",
          "target": "disease_neonatal_cholestasis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能有助于保护肝脏功能"
        },
        {
          "source": "drug_lactulose",
          "target": "disease_neonatal_cholestasis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "改善肠道功能可能减轻症状"
        },
        {
          "source": "drug_n_acetylcysteine",
          "target": "disease_neonatal_cholestasis",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "已提示对肝脏的保护作用"
        },
        {
          "source": "drug_metformin",
          "target": "disease_neonatal_cholestasis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "循证支持在代谢方面的潜在联系"
        },
        {
          "source": "target_bile_acid_transporters",
          "target": "pathway_bile_acid_homeostasis",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "在胆汁酸代谢中发挥核心作用"
        },
        {
          "source": "pathway_bile_acid_homeostasis",
          "target": "disease_neonatal_cholestasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "直接影响胆汁的产生与排泄"
        },
        {
          "source": "drug_ursodeoxycholic_acid",
          "target": "disease_neonatal_cholestasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "药物用于改善胆道疾病相关临床表现"
        },
        {
          "source": "drug_silibinin",
          "target": "disease_neonatal_cholestasis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "对胆汁酸代谢有改善作用"
        },
        {
          "source": "drug_ursodeoxycholic_acid",
          "target": "n_ot_ursodeoxycholic_acid",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的副作用或离靶作用"
        },
        {
          "source": "n_ot_ursodeoxycholic_acid",
          "target": "n_rp_ursodeoxycholic_acid",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路可能参与"
        },
        {
          "source": "n_rp_ursodeoxycholic_acid",
          "target": "n_adv_ursodeoxycholic_acid",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv_ursodeoxycholic_acid",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，可能抵消药物的益处"
        },
        {
          "source": "drug_silibinin",
          "target": "n_ot_silibinin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的副作用或离靶作用"
        },
        {
          "source": "n_ot_silibinin",
          "target": "n_rp_silibinin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路可能参与"
        },
        {
          "source": "n_rp_silibinin",
          "target": "n_adv_silibinin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv_silibinin",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，可能抵消药物的益处"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_ursodeoxycholic_acid",
          "name": "Ursodeoxycholic acid"
        },
        "score": 0.84,
        "graph_snapshot_ref": "GE_H1_round5",
        "key_assumptions": [
          "Ursodeoxycholic acid effectively supports bile acid transporters and improves neonatal cholestasis",
          "Risk of adverse effects acknowledged but clinically outweighed by therapeutic benefits"
        ],
        "caveats": [
          "Potential adverse effects warrant monitoring in clinical use"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_silibinin",
          "name": "Silibinin"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H2_round5",
        "key_assumptions": [
          "Silibinin positively influences bile acid metabolism",
          "Clinical usage for neonatal cholestasis established but potential adverse effects noted"
        ],
        "caveats": [
          "Adverse effects need further clarification in clinical studies"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_cholestyramine",
          "name": "Cholestyramine"
        },
        "score": 0.71,
        "graph_snapshot_ref": "GE_H3_round5",
        "key_assumptions": [
          "Cholestyramine's mechanism of reducing bile acid reabsorption is beneficial",
          "Safety and efficacy in neonatal cholestasis require further investigation"
        ],
        "caveats": [
          "Limited data on safety specifically for neonates"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H7",
        "candidate": {
          "id": "drug_bile_acid_sequestrants",
          "name": "Bile acid sequestrants"
        },
        "score": 0.68,
        "graph_snapshot_ref": "GE_H7_round5",
        "key_assumptions": [
          "Bile acid sequestrants positively affect bile acid metabolism",
          "Clinical efficacy and safety require elucidation"
        ],
        "caveats": [
          "Benefit in patients yet to be decisively established"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "score": 0.65,
        "graph_snapshot_ref": "GE_H5_round5",
        "key_assumptions": [
          "Fenofibrate supports lipid metabolism that may influence bile acids",
          "Safety documentation in neonates is sparse"
        ],
        "caveats": [
          "Potential safety issues for neonates are significant"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Ursodeoxycholic acid → Bile acid transporters → Neonatal cholestasis",
          "reason": "Established mechanism and clinical relevance with monitoring of adverse effects."
        },
        {
          "pattern": "Silibinin → Bile acid transporters → Neonatal cholestasis",
          "reason": "Strong support for metabolic modulation towards indication."
        }
      ],
      "remaining_gaps": [
        "Further clarification of safety profiles for drugs primarily assessed in adult populations."
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "X",
            "Y"
          ],
          "impact_summary": "Focused on bile-acid related pathways; clarity increased on neonatal safety."
        },
        {
          "round": 2,
          "seeds": [
            "Z",
            "W"
          ],
          "impact_summary": "Brought in different drug classes; clarity on indications enhanced."
        }
      ],
      "lessons": [
        "Ensuring that newly introduced candidates address gaps in clinical applicability is crucial.",
        "Monitoring adverse effects in neonates is vital for safe therapeutic strategies."
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "Emphasize the need for clarity around potential side effects of drugs in neonates."
      },
      {
        "role": "Skeptic",
        "patch": "Identify specific safety concerns for each candidate; clearly differentiate adverse risk profiles."
      },
      {
        "role": "Explorer",
        "patch": "Explore additional candidates with distinct mechanisms or targets; avoid redundant submissions."
      }
    ],
    "heuristics": [
      {
        "when": "baby with cholestasis",
        "then": "Focus on interventions that directly affect bile acid pathways and safety."
      },
      {
        "when": "evaluating drugs",
        "then": "Consider preclinical models of neonates to guide clinical applicability."
      }
    ]
  }
}